SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -33.3% | 2,000 | -8.3% | 0.00% | – |
| Q4 2019 | $3,000 | -57.1% | 2,180 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 2,180 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -65.2% | 2,180 | -0.1% | 0.00% | – |
| Q1 2019 | $23,000 | -4.2% | 2,182 | -3.1% | 0.00% | – |
| Q4 2018 | $24,000 | -20.0% | 2,251 | -10.2% | 0.00% | – |
| Q3 2018 | $30,000 | +15.4% | 2,507 | +14.2% | 0.00% | – |
| Q2 2018 | $26,000 | -23.5% | 2,196 | +0.7% | 0.00% | – |
| Q1 2018 | $34,000 | +17.2% | 2,180 | -1.3% | 0.00% | – |
| Q4 2017 | $29,000 | +866.7% | 2,208 | +1119.9% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 181 | +0.6% | 0.00% | – |
| Q2 2017 | $2,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
| DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
| Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
| Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
| BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
| BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
| MORGAN STANLEY | 12,500 | $100,000 | 0.00% |